Newswise — HOUSTON ― The University of Texas MD Anderson Cancer Center will make a special announcement at 9 a.m. on Thursday, March 24, about institutional efforts to usher in a new era for immunotherapy. The announcement live stream will be available at www.MDAnderson.org. Opportunities are available for interviews following the announcement.
Unlike the traditional pillars of cancer care — surgery, radiation, chemotherapy and targeted therapies — immunotherapy unleashes the immune system to eliminate cancer. Immunotherapy options, including immune checkpoint inhibitors and cellular therapies, have transformed cancer care over the past decade. However, not all patients benefit from these treatment options. MD Anderson’s goal is to change that and to bring the benefits of immunotherapy to all patients.
The special announcement will detail plans for this new effort and will feature remarks from:
- James P. Allison, Ph.D. – Nobel Laureate and regental chair of Immunology
- Padmanee Sharma, M.D., Ph.D. – professor of Genitourinary Medical Oncology and Immunology
- Raghu Kalluri, M.D., Ph.D. – professor and chair of Cancer Biology
- Peter WT Pisters, M.D. – president of MD Anderson
- Giulio Draetta, M.D., Ph.D. – chief scientific officer at MD Anderson
Announcement Details
Date: Thursday, March 24, 2022
Time: 9-10 a.m. CT
URL: http://www.MDAnderson.org
Note: Interviews with experts are available following the announcement. Please contact [email protected] to request and schedule an interview.
- 30 -
RSS